The Impact of COVID-19 is included in Parkinson Disease Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Parkinson Disease Trends and Forecast
The future of the global parkinson disease market looks promising with opportunities in the carbidopa-levodopa, dopamine agonists, MAO-B inhibitors, COMT inhibitors, and anticholinergics markets. The global parkinson disease market is expected to reach an estimated $8.8 billion by 2030 with a CAGR of 6.1% from 2024 to 2030. The major drivers for this market are rising aging population, advances in diagnostic technologies, and increasing healthcare expenditure in emerging economies.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Parkinson Disease by Segment
The study includes a forecast for the global parkinson disease by drug class, distribution channel, and region.
Parkinson Disease Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:
• Carbidopa-Levodopa
• Dopamine Agonists
• Mao-B Inhibitors
• Comt Inhibitors
• Anticholinergics
• Others
Parkinson Disease Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
Parkinson Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Parkinson Disease Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies parkinson disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the parkinson disease companies profiled in this report include-
• Cerevel Therapeutics
• Novartis
• Teva Pharmaceutical Industries
• Merck & Co.
• GlaxoSmithKline
• AbbVie
• H. Lundbeck
Parkinson Disease Market Insights
Lucintel forecasts that retail pharmacy will remain the largest segment over the forecast period due to ease of availbility.
North America will remain the largest region over the forecast period due to large number of important participants, high disposable income, high costs for healthcare, and an established healthcare system in this area.
Features of the Global Parkinson Disease Market
Market Size Estimates: Parkinson disease market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Parkinson disease market size by drug class, distribution channel, and region in terms of value ($B).
Regional Analysis: Parkinson disease market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug class, distribution channel, and regions for the parkinson disease market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the parkinson disease market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the parkinson disease market size?
Answer: The global parkinson disease market is expected to reach an estimated $8.8 billion by 2030.
Q2. What is the growth forecast for parkinson disease market?
Answer: The global parkinson disease market is expected to grow with a CAGR of 6.1% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the parkinson disease market?
Answer: The major drivers for this market are rising aging population, advances in diagnostic technologies, and increasing healthcare expenditure in emerging economies.
Q4. What are the major segments for parkinson disease market?
Answer: The future of the global parkinson disease market looks promising with opportunities in the carbidopa-levodopa, dopamine agonists, MAO-B inhibitors, COMT inhibitors, and anticholinergics markets.
Q5. Who are the key parkinson disease market companies?
Answer: Some of the key parkinson disease companies are as follows:
• Cerevel Therapeutics
• Novartis
• Teva Pharmaceutical Industries
• Merck & Co.
• GlaxoSmithKline
• AbbVie
• H. Lundbeck
Q6. Which parkinson disease market segment will be the largest in future?
Answer: Lucintel forecasts that retail pharmacy will remain the largest segment over the forecast period due to ease of availbility.
Q7. In parkinson disease market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to large number of important participants, high disposable income, high costs for healthcare, and an established healthcare system in this area.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the parkinson disease market by drug class (carbidopa-levodopa, dopamine agonists, MAO-B inhibitors, COMT inhibitors, anticholinergics, and others), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Parkinson Disease Market, Parkinson Disease Market Size, Parkinson Disease Market Growth, Parkinson Disease Market Analysis, Parkinson Disease Market Report, Parkinson Disease Market Share, Parkinson Disease Market Trends, Parkinson Disease Market Forecast, Parkinson Disease Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Parkinson Disease Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Parkinson Disease Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Parkinson Disease Market by Drug Class
3.3.1: Carbidopa-Levodopa
3.3.2: Dopamine Agonists
3.3.3: MAO-B Inhibitors
3.3.4: COMT Inhibitors
3.3.5: Anticholinergics
3.3.6: Others
3.4: Global Parkinson Disease Market by Distribution Channel
3.4.1: Hospital Pharmacy
3.4.2: Retail Pharmacy
3.4.3: Online Pharmacy
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Parkinson Disease Market by Region
4.2: North American Parkinson Disease Market
4.2.2: North American Parkinson Disease Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
4.3: European Parkinson Disease Market
4.3.1: European Parkinson Disease Market by Drug Class: Carbidopa-Levodopa, Dopamine Agonists, MAO-B Inhibitors, COMT Inhibitors, Anticholinergics, and Others
4.3.2: European Parkinson Disease Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
4.4: APAC Parkinson Disease Market
4.4.1: APAC Parkinson Disease Market by Drug Class: Carbidopa-Levodopa, Dopamine Agonists, MAO-B Inhibitors, COMT Inhibitors, Anticholinergics, and Others
4.4.2: APAC Parkinson Disease Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
4.5: ROW Parkinson Disease Market
4.5.1: ROW Parkinson Disease Market by Drug Class: Carbidopa-Levodopa, Dopamine Agonists, MAO-B Inhibitors, COMT Inhibitors, Anticholinergics, and Others
4.5.2: ROW Parkinson Disease Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Parkinson Disease Market by Drug Class
6.1.2: Growth Opportunities for the Global Parkinson Disease Market by Distribution Channel
6.1.3: Growth Opportunities for the Global Parkinson Disease Market by Region
6.2: Emerging Trends in the Global Parkinson Disease Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Parkinson Disease Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Parkinson Disease Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Cerevel Therapeutics
7.2: Novartis
7.3: Teva Pharmaceutical Industries
7.4: Merck & Co.
7.5: GlaxoSmithKline
7.6: AbbVie
7.7: H. Lundbeck
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Parkinson Disease Market Report.